FAKTOR-OPTIONSSCHEIN - MERCK & CO. | Real-time Boerse Frankfurt Warrants 13:02:13 03/06/2024 BST | ||
| 0.55 EUR | -1.79% |
|
| 1 month | +9.80% | ||
| 6 months | -61.11% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 03/06/24 | 0.55 | -1.79% |
| 31/05/24 | 0.56 | -1.75% |
| 30/05/24 | 0.57 | +3.64% |
| 29/05/24 | 0.55 | 0.00% |
| 28/05/24 | 0.55 | +10.00% |
Real-time Boerse Frankfurt Warrants
Last update June 03, 2024 at 01:02 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
Société Générale
|
| WKN | SF5DRF |
| ISIN | DE000SF5DRF8 |
| Date issued | 06/10/2021 |
| Strike | 83.13 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 9.99 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.5 € |
|---|---|
| Lowest since issue | 0.45 € |
| Spread | 0.01 € |
| Spread % | 1.79% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5
USD
Average target price
141.9
USD
Spread / Average Target
+13.01%
- Stock Market
- Certificates
- Certificat
